13FPulse
中
PC

PCVX VAXCYTE INC

2026Q2 · CUSIP 92243G108 · Sector: Healthcare & Biotech

Funds left

Funds are exiting, but the price is holding

Funds that own it
325
Institutions that reported holding it to the SEC
Net decrease in holders
9
Last quarter 334 → now 325
How unusual is that
Bottom 20%
Stronger than only 14% of US stocks
What the filings say, in one paragraph

325 funds held PCVX at the end of 2026Q2, down 9 from the quarter before. Buying has faded, though the price is holding up. On the business itself, return on equity is -38.6%. PCVX has had 9 buying rushes in its history, and the price moved +11.0% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2020Q3: holders=59 2020Q4: holders=82 2021Q1: holders=76 2021Q2: holders=75 2021Q3: holders=77 2021Q4: holders=87 2022Q1: holders=87 2022Q2: holders=106 2022Q3: holders=125 2022Q4: holders=200 2023Q1: holders=186 2023Q2: holders=197 2023Q3: holders=199 2023Q4: holders=221 2024Q1: holders=249 2024Q2: holders=264 2024Q3: holders=327 2024Q4: holders=324 2025Q1: holders=312 2025Q2: holders=294 2025Q3: holders=285 2025Q4: holders=295 2026Q1: holders=334 2026Q2: holders=325 -75 -37.5 +0 +37.5 +75 53202351 20Q321Q222Q122Q423Q324Q225Q125Q426Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 9 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2026Q1 Top 10% +17.6% —
2024Q3 Top 5% -1.9% -7.8%
2024Q2 Top 20% +46.4% +17.5%
2024Q1 Top 10% +2.3% +6.0%
2023Q2 Top 20% +3.4% +4.5%
2022Q4 Top 5% -13.9% +11.6%
2022Q3 Top 10% +8.1% +2.0%
2022Q2 Top 10% -3.2% +75.9%
2020Q3 Top 20% -17.6% -21.5%

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
168
Change in large funds
+5
Total value they hold
$9.7B
Funds buying for the first time
50
Funds that sold out entirely
59
Price change that quarter
+27.1%
Funds holding puts (bearish)
9
Funds holding calls (bullish)
11

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
—
EPS (TTM)
$-7.64
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Net margin
—
ROE
-38.6%
Debt ratio
12.1%
FCF (TTM)
-$894M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2021-09-30: EPS -0.51 2021-12-31: EPS -0.55 2022-03-31: EPS -0.68 2022-06-30: EPS -0.80 2022-09-30: EPS -0.93 2022-12-31: EPS -1.03 2023-03-31: EPS -0.70 2023-06-30: EPS -0.70 2023-09-30: EPS -0.91 2023-12-31: EPS -1.83 2024-03-31: EPS -0.85 2024-06-30: EPS -1.10 2024-09-30: EPS -0.83 2024-12-31: EPS -1.02 2025-03-31: EPS -1.04 2025-06-30: EPS -1.22 2025-09-30: EPS -1.56 2025-12-31: EPS -1.81 2026-03-31: EPS -2.30 2026-06-30: EPS -1.97 -2.53 -1.26 0.00 20212022202320242025202606/26 EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

Quarterly free cash flow
-283M-141M0K 20192020202120222023202420252026
Latest quarter $-283M (2026-03-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.